On the Origin of Rheumatoid Arthritis: The Impact of Environment and Genes—A Population Based Twin Study

Svendsen, Anders J.; Kyvik, Kirsten O.; Houen, Gunnar; Junker, Peter; Christensen, Kaare; Christiansen, Lene; Nielsen, Christian; Skytthe, Axel; Hjelmborg, Jacob V.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: Rheumatoid arthritis (RA) is an autoimmune disease with a complex origin. Previous studies have reported heritability estimates on RA at about 60%. Only 16% of the genetic background of the disease has been disclosed so far. The purpose of the present investigation was to provide an optimized estimate on the heritability of RA and to study the recurrence risk in a nationwide Caucasian twin population. Methods and Findings: In a mail survey addressed to 56.707 twin individuals, RA was reported by 479 individuals, mean age 52 (range 16–73). Respondents underwent an interview and clinical examination. Ascertainment probability was 80%. RA was confirmed in 162 twin individuals yielding a prevalence at 0.37% (95% CI 0.31–0.43). The mean discordance time was 19 years (range 0–57). The concordance was 9.1% (95% CI 1.9 to 24.3) in MZ, 6.4% (95% CI 2.1 to 14.3) in DZss. The increased relative risk of attracting RA conditioned on having an affected cotwin compared to the background population risk was 24.6 to 35.4 in MZ twins and 17.3 to 31.6 in DZss twins. The correlation coefficients were 0.60 (0.33 to 0.78) in monozygotic (MZ) and 0.55 (0.33 to 0.72) in dizygotic same sexed (DZss) pairs. Twelve percent (95% CI 0–76%) of the phenotypic variance in the liability to RA was due to additive genetic effects, 50% (95% CI 0–72%) to shared environmental effects and 38% (95% CI 17–61%) to non-shared environmental effects. Conclusions: This study emphasizes that family factors are important for the development of RA. Although genetic effectors are important, shared and non-shared environmental triggers and/or epigenetic stochastic events seem to be even more significant. However, it should be borne in mind that the genetic and non-genetic components may not be the same across disease subsets.


Related Articles

  • Genome-wide association studies may be misinterpreted: genes versus heritability. Vineis, Paolo; E.Pearce, Neil // Carcinogenesis;Sep2011, Vol. 32 Issue 9, p1295 

    Much of the literature on genome-wide association studies (GWAS) is based on the premise that an important proportion of common diseases is heritable and that this proportion is likely to be due to genetic variants detectable with extensive scans of the DNA. Heritability is estimated from family...

  • Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Sokka, T.; Mäkinen, H.; Hannonen, P.; Pincus, T. // Rheumatology;Jun2007, Vol. 46 Issue 6, p1020 

    Objective. To analyse the proportion of individuals in the general population over age 50 who do not meet American College of Rheumatology (ACR) criteria for rheumatoid arthritis (RA) remission, and OMERACT criteria for minimal disease activity (MDA), and to compare results to RA patients.

  • Measures of Rheumatoid Arthritis Disease Activity in Australian Clinical Practice. Taylor, Andrew; Bagga, Hanish // ISRN Rheumatology;2011, Special section p1 

    Objectives. To investigate which rheumatoid arthritis (RA) disease activity measures are being collected in patients receiving glucocorticoids, non-biologic or biologic disease-modifying antirheumatic drugs (DMARDs) in Australian rheumatology practice. Methods. A retrospective audit of medical...

  • Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis. Russell, Anthony; Beresniak, Ariel; Bessette, Louis; Haraoui, Boulos; Rahman, Proton; Thorne, Carter; Maclean, Ross; Dupont, Danielle // Clinical Rheumatology;Apr2009, Vol. 28 Issue 4, p403 

    To assess the cost-effectiveness of abatacept compared to different biologic treatment strategies for moderate to severe rheumatoid arthritis based on current medical practices in Canada. A model was constructed to assess the cost-effectiveness of various biologic treatments over a 2-year time...

  • Environmental and genetic contributions to indicators of oral malodor in twins. Bretz, Walter A.; Biesbrock, Aaron; Corby, Patricia M.; Corby, Andrea L.; Bretz, Walter G.; Wessel, Jennifer; Schork, Nicholas J. // Twin Research & Human Genetics;Dec2011, Vol. 14 Issue 6, p568 

    This study aimed to: (1) determine concordance rates of self-reported and subjectively determined indicators of oral malodor in twins; (2) determine the relative contributions of genetic and environmental factors to levels of volatile sulfur compounds (VSCs) in intraoral and exhaled breath....

  • Expert Panel Workshop Consensus Statement on the Role of the Environment in the Development of Autoimmune Disease. Parks, Christine G.; Miller, Frederick W.; Pollard, Kenneth Michael; Selmi, Carlo; Germolec, Dori; Joyce, Kelly; Rose, Noel R.; Humble, Michael C. // International Journal of Molecular Sciences;Aug2014, Vol. 15 Issue 8, p14269 

    Autoimmune diseases include 80 or more complex disorders characterized by self-reactive, pathologic immune responses in which genetic susceptibility is largely insufficient to determine disease onset. In September 2010, the National Institute of Environmental Health Sciences (NIEHS) organized an...

  • Depresión en pacientes con enfermedades autoinmunes más frecuentes en reumatología. Barguil-Díaz, Ivón Cecilia; Gómez-Mejía, Catherine; Ramírez-González, Julián Andrés; Zapata-Carmona, Sandra Cristina // Medicina UPB;ene-jun2012, Vol. 31 Issue 1, p34 

    Autoimmune diseases are highly prevalent today. These are diseases that sometimes, for their symptoms, can cause mood disturbances in the patient, with depression being one the most common disorders. Hence the importance of recognizing the frequency of depressive disorder occurring in patients...

  • Rheumatologic manifestations of histoplasmosis: a review. Sizemore, Travis C. // Rheumatology International;Dec2013, Vol. 33 Issue 12, p2963 

    Histoplasmosis is an important cause of morbidity in endemic areas of the USA. Infection is often asymptomatic but can cause a broad spectrum of pathology. Less commonly, histoplasmosis can present with a wide-range of rheumatologic manifestations. The aim of this review is to provide a synopsis...

  • Hemophagocytic syndrome in elderly patients with underlying autoimmune diseases. Tabata, Rie; Tabata, Chiharu; Terada, Makoto; Nagai, Tomoko // Clinical Rheumatology;Apr2009, Vol. 28 Issue 4, p461 

    In patients with autoimmune disease-associated hemophagocytic syndrome (AAHS), the clinical features may differ from hemophagocytic syndrome (HPS) of other etiologies, and new criteria for AAHS have been proposed. Since bone marrow (BM) circumstances are changed according to aging, here we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics